Huiqin Yang
Research Fellow
Email: huiqin.yang@york.ac.uk
Tel: 01904 321064
Fax: 01904 321041
Yang is a research fellow in evidence synthesis at CRD, responsible for undertaking systematic reviews in health care. She is actively involved in the technology assessment review team for evaluating clinical effectiveness and safety of health technologies.
Yang has a PhD in Health Sciences and an MSc. in Evidence Based Practice (Health Services Research) from the University of York. Before joining CRD she studied for her PhD in the Department of Health Sciences at the University of York. Her PhD thesis principally investigated the decision accuracy and information use of UK nurses’ risk assessments in critical care using experimental designs and statistical modelling.
Yang has a nursing background and previously worked as a senior nurse and clinical supervisor in a city centre hospital in China. Her research interests include evidence based healthcare, clinical decision making and clinical judgement, and research implementation.Current research projects
Bone turnover markers for monitoring the response to osteoporosis treatment: the secondary prevention of fractures, and primary prevention of fractures in high risk groupsSelected publications
Yang H, Epstein D, Bojke L, Craig D, Light K, Bruce I, Sculpher M, Woolacott N. Golimumab for the treatment of psoriatic arthritis. Health Technol Assess. 15(Supp 1):87-96
Yang H, Thompson C. Nurses' risk assessment judgements: a confidence calibration study. J Adv Nurs. 2010; 66(12):2751-60
Yang H, Thompson C. The effects of clinical experience on nurses' critical event risk assessment judgements in paper based and high fidelity simulated conditions: A comparative judgement analysis. Int J Nurs Stud. 2010;48(4):429-37
Rodgers M, Soares M, Epstein D, Yang H, Fox D, Eastwood A. Bevacizumab in combination with a taxane for the first-line treatment of HER2-negative metastatic breast cancer. Health Technol Assess. 2010;15(Suppl 1):1-12
Rodgers M, Epstein D, Bojke L, Yang H, Craig D, Fonseca T, Myers L, Bruce I, Chalmers R, Sutton A, Sculpher M, Woolacott N. Etanercept, Infliximab and Adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation. Health Technol Assess 2011;15(10):1-329
Thompson C; Yang, H, Nurses' decisions, irreducible uncertainty and maximizing nurses' contribution to patient safety. Healthcare Quarterly 2009; 12(Sp): e178-185